ANNA RICHO
CIK 1199306 · SVP & CCO · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.93M
Companies
4
Total Filings
51
Lifetime Open-Market Net
-$8.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ILMN | Director | 8,527 | $160.97 | $1.37M | $0 | 3 | 2026-05-22 |
| EXCw | Director | 11,337 | — | — | $0 | 12 | 2026-04-29 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 0 | $8.22 | $0 | $0 | 3 | 2021-11-24 |
| AMGN | SVP & CCO | 52,248 | $355.20 | $18.56M | -$8.53M | 33 | 2012-08-01 |
Recent Filings · Page 6 of 6
51 filingsForm 4 transactions across all companies, newest first.
Showing 51–51 of 51
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.